BLACKROCK ENHAN LRG CAP CORE (CII) Fundamental Analysis & Valuation

NYSE:CII • US09256A1097

21.98 USD
+0.48 (+2.23%)
Last: Mar 10, 2026, 08:13 PM

This CII fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, CII scores 2 out of 10 in our fundamental rating. CII was compared to 0 industry peers in the Unkown industry. CII scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CII has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. CII Profitability Analysis

1.1 Basic Checks

  • CII had positive earnings in the past year.
  • In the past year CII had a positive cash flow from operations.
CII Yearly Net Income VS EBIT VS OCF VS FCFCII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 50M 100M 150M

1.2 Ratios

Industry RankSector Rank
ROA 12.23%
ROE 12.62%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CII Yearly ROA, ROE, ROICCII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 5 10 15

1.3 Margins

Industry RankSector Rank
OM N/A
PM (TTM) 1392.86%
GM 8.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CII Yearly Profit, Operating, Gross MarginsCII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 500 1K 1.5K

5

2. CII Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, CII has less shares outstanding
  • CII has a worse debt/assets ratio than last year.
CII Yearly Shares OutstandingCII Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 10M 20M 30M 40M
CII Yearly Total Debt VS Total AssetsCII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • CII has an Altman-Z score of 18.01. This indicates that CII is financially healthy and has little risk of bankruptcy at the moment.
  • CII has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 18.01
ROIC/WACCN/A
WACCN/A
CII Yearly LT Debt VS Equity VS FCFCII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 0.05 indicates that CII may have some problems paying its short term obligations.
  • CII has a Quick Ratio of 0.05. This is a bad value and indicates that CII is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
CII Yearly Current Assets VS Current LiabilitesCII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 5M 10M 15M 20M

0

3. CII Growth Analysis

3.1 Past

  • The earnings per share for CII have decreased strongly by -11.85% in the last year.
  • CII shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.46%.
EPS 1Y (TTM)-11.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.48%
Revenue 1Y (TTM)-19.46%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-35.37%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CII Yearly Revenue VS EstimatesCII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M

2

4. CII Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 7.58, the valuation of CII can be described as very cheap.
  • When comparing the Price/Earnings ratio of CII to the average of the S&P500 Index (26.25), we can say CII is valued rather cheaply.
Industry RankSector Rank
PE 7.58
Fwd PE N/A
CII Price Earnings VS Forward Price EarningsCII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.92
EV/EBITDA N/A
CII Per share dataCII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. CII Dividend Analysis

5.1 Amount

  • CII has a Yearly Dividend Yield of 17.06%, which is a nice return.
  • Compared to an average S&P500 Dividend Yield of 1.82, CII pays a better dividend.
Industry RankSector Rank
Dividend Yield 17.06%

5.2 History

  • CII has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
CII Yearly Dividends per shareCII Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • CII pays out 53.85% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP53.85%
EPS Next 2YN/A
EPS Next 3YN/A
CII Yearly Income VS Free CF VS DividendCII Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2023 2024 50M 100M 150M
CII Dividend Payout.CII Dividend Payout, showing the Payout Ratio.CII Dividend Payout.PayoutRetained Earnings

CII Fundamentals: All Metrics, Ratios and Statistics

BLACKROCK ENHAN LRG CAP CORE

NYSE:CII (3/10/2026, 8:13:19 PM)

21.98

+0.48 (+2.23%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)03-05
Earnings (Next)N/A
Inst Owners24.31%
Inst Owner Change-0.63%
Ins Owners0.01%
Ins Owner Change0%
Market Cap899.42M
Revenue(TTM)8.40M
Net Income(TTM)117.00M
Analysts0
Price TargetN/A
Short Float %1.61%
Short Ratio5
Dividend
Industry RankSector Rank
Dividend Yield 17.06%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP53.85%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date06-15
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.58
Fwd PE N/A
P/S 107.07
P/FCF 6.92
P/OCF 6.92
P/B 0.97
P/tB 0.97
EV/EBITDA N/A
EPS(TTM)2.9
EY13.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.18
FCFY14.45%
OCF(TTM)3.18
OCFY14.45%
SpS0.21
BVpS22.63
TBVpS22.63
PEG (NY)N/A
PEG (5Y)N/A
Graham Number38.43
Profitability
Industry RankSector Rank
ROA 12.23%
ROE 12.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1392.86%
GM 8.21%
FCFM 1547.62%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 111.11%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 18.01
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.46%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-35.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-100.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80%
OCF growth 3YN/A
OCF growth 5YN/A

BLACKROCK ENHAN LRG CAP CORE / CII FAQ

Can you provide the ChartMill fundamental rating for BLACKROCK ENHAN LRG CAP CORE?

ChartMill assigns a fundamental rating of 2 / 10 to CII.


What is the valuation status for CII stock?

ChartMill assigns a valuation rating of 2 / 10 to BLACKROCK ENHAN LRG CAP CORE (CII). This can be considered as Overvalued.


What is the profitability of CII stock?

BLACKROCK ENHAN LRG CAP CORE (CII) has a profitability rating of 1 / 10.


How sustainable is the dividend of BLACKROCK ENHAN LRG CAP CORE (CII) stock?

The dividend rating of BLACKROCK ENHAN LRG CAP CORE (CII) is 5 / 10 and the dividend payout ratio is 53.85%.